MARCHIANO', SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 2.005
AS - Asia 1.443
EU - Europa 998
SA - Sud America 217
Continente sconosciuto - Info sul continente non disponibili 153
AF - Africa 32
OC - Oceania 3
Totale 4.851
Nazione #
US - Stati Uniti d'America 1.945
SG - Singapore 701
IT - Italia 238
CN - Cina 210
IE - Irlanda 210
VN - Vietnam 200
RU - Federazione Russa 165
HK - Hong Kong 158
BR - Brasile 155
FR - Francia 84
DE - Germania 63
GB - Regno Unito 41
IN - India 32
CA - Canada 28
FI - Finlandia 27
PL - Polonia 27
SE - Svezia 26
MX - Messico 22
TR - Turchia 21
NL - Olanda 20
UA - Ucraina 20
IQ - Iraq 19
AR - Argentina 16
AT - Austria 16
BD - Bangladesh 16
ES - Italia 16
JP - Giappone 15
BE - Belgio 13
EC - Ecuador 12
ZA - Sudafrica 12
KR - Corea 10
UY - Uruguay 9
VE - Venezuela 9
LB - Libano 8
CO - Colombia 7
ID - Indonesia 7
MA - Marocco 7
SA - Arabia Saudita 7
PK - Pakistan 6
LT - Lituania 5
TW - Taiwan 5
UZ - Uzbekistan 5
AL - Albania 4
CH - Svizzera 4
CL - Cile 4
PY - Paraguay 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
EG - Egitto 3
HU - Ungheria 3
IL - Israele 3
JM - Giamaica 3
AU - Australia 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
GR - Grecia 2
KE - Kenya 2
MY - Malesia 2
NI - Nicaragua 2
NO - Norvegia 2
PS - Palestinian Territory 2
SV - El Salvador 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
IM - Isola di Man 1
IR - Iran 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
ME - Montenegro 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 4.698
Città #
Singapore 548
Chandler 322
Dublin 206
San Jose 186
Hong Kong 157
Ashburn 125
San Mateo 119
Dong Ket 117
Perugia 108
Santa Clara 76
Ann Arbor 63
Moscow 60
Beijing 55
Los Angeles 52
Boardman 51
Medford 51
Princeton 50
Lauterbourg 44
Altamura 40
Lawrence 40
Wilmington 36
Andover 30
New York 30
Warsaw 25
Ho Chi Minh City 23
The Dalles 21
Hanoi 20
Munich 20
Orem 20
São Paulo 20
Dallas 19
Houston 18
Redmond 17
Saint Petersburg 14
Tokyo 14
Brussels 13
Chicago 13
Council Bluffs 12
Helsinki 12
Brooklyn 11
Des Moines 11
Frankfurt am Main 11
Redwood City 11
Den Haag 10
Columbus 9
London 9
Seoul 9
Stockholm 9
Johannesburg 8
Mexico City 8
Nuremberg 8
Vienna 8
Denver 7
Izmir 7
Montreal 7
Norwalk 7
Phoenix 7
Toronto 7
Rome 6
San Francisco 6
San Paolo di Civitate 6
Amsterdam 5
Ankara 5
Baghdad 5
Chennai 5
Dearborn 5
Falls Church 5
Florence 5
Guayaquil 5
Manchester 5
Quito 5
Turku 5
Bauru 4
Buffalo 4
Cambridge 4
Caracas 4
Contagem 4
Dhaka 4
Jacksonville 4
Poplar 4
Rio de Janeiro 4
Secaucus 4
Shanghai 4
Woodbridge 4
Atlanta 3
Baku 3
Betim 3
Bexley 3
Buenos Aires 3
Da Nang 3
Guangzhou 3
Haiphong 3
Hải Dương 3
Istanbul 3
Jeddah 3
Kanpur 3
Ludhiana 3
Medellín 3
Ninh Bình 3
Oklahoma City 3
Totale 3.180
Nome #
The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines 149
The bile acid receptor GPBAR1 regulates the M1/M2 phenotype of intestinal macrophages and activation of gpbar1 rescues mice from murine colitis 148
A Comprehensive Analysis of Small Heterodimer Partner (SHP) Target Genes in Hepatic Stellate Cells and the Discovery of a New Class of SHP Agonists That Reduces Liver Fibrosis 144
BAR502, a Dual FXR and GPBAR1 Agonist, Reverses Steatosis and Fibrosis in Rodent Model of NASH By Modulating Authophagic Genes 141
Analysis of Gastric Cancer Transcriptome Allows the Identification of Histotype Specific Molecular Signatures With Prognostic Potential 133
Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis 124
The aryl hydrocarbon receptor (AhR) mediates the counter-regulatory effects of pelargonidins in models of inflammation and metabolic dysfunctions 118
Identification of Cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1 114
BAR501, A SELECTIVE GPBAR1 AGONIST, PROMOTES ADIPOSE TISSUE BROWNING AND AUTOPHAGY AND IMPROVES LIPID METABOLISM AND STEATO-HEPATITIS IN MICE FEED A HIGH FAT DIET 111
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 111
241 - GPBAR1 (TGR5) is a Modulator of Liver Immunity and Reverses Liver Inflammation in a Mouse Models of Acute Hepatitis 107
Genetic and Pharmacological Dissection of the Role of Spleen Tyrosine Kinase (Syk) in Intestinal Inflammation and Immune Dysfunction in Inflammatory Bowel Diseases 106
Discovery of a Novel Multi-Strains Probiotic Formulation with Improved Efficacy toward Intestinal Inflammation 105
BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis 104
BAR130, A HYODEOXYCHOLIC ACID DERIVATIVE AS THE FIRST EXAMPLE OF DUAL LXR alpha/GPBAR1 AGONIST 103
The Bile Acid Receptor GPBAR1 Modulates CCL2/CCR2 Signaling at the Liver Sinusoidal/Macrophage Interface and Reverses Acetaminophen-Induced Liver Toxicity 102
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling 102
Discovery of ((1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl)ureidyl derivatives as selective non-steroidal agonists of the G-protein coupled bile acid receptor-1 101
Bile Acids Activated Receptors in Inflammatory Bowel Disease 100
Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH 99
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis 98
The bile acid activated receptors GPBAR1 and FXR exert antagonistic effects on autophagy 98
Disruption of TFG beta-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand 94
Discovery of a Potent and Orally Active Dual GPBAR1/CysLT1R Modulator for the Treatment of Metabolic Fatty Liver Disease 94
Tu1546 – Gpbar1 is a Modulator of Liver Immunity and Its Agonism Reverses Acetaminophen-Induced Hepatotoxicity by Modulating Recruitment of Liver Macrophages 93
GLP-1 Mediates Regulation of Colonic ACE2 Expression by the Bile Acid Receptor GPBAR1 in Inflammation 93
Mo2014 – Comparative Effects of Bar502, a Dual Fxr and Gpbar1 Agonist, Obeticholic Acid and Ursodeoxycholic Acid in a Rodent Model of Nash 91
Metabolic variability of a multispecies probiotic preparation impacts on the anti-inflammatory activity 90
Gpbar1 agonism promotes a Pgc-1α-dependent browning of white adipose tissue and energy expenditure and reverses diet-induced steatohepatitis in mice 89
Novel Isoxazole Derivatives with Potent FXR Agonistic Activity Prevent Acetaminophen-Induced Liver Injury 89
Divergent effectiveness of multispecies probiotic preparations on intestinal microbiota structure depends on metabolic properties 88
Sa1518 – Mechanism of Acute Liver Decompensation Caused by Obeticholic Acid in Cholestasis is Fxr Dependent 88
Epoxide functionalization on cholane side chains in the identification of G-protein coupled bile acid receptor (GPBAR1) selective agonists 88
GPBAR1 Activation by C6-Substituted Hyodeoxycholane Analogues Protect against Colitis 88
Nanotraps with biomimetic surface as decoys for chemokines 87
GPBAR1 Functions as Gatekeeper for Liver NKT Cells and provides Counterregulatory Signals in Mouse Models of Immune-Mediated Hepatitis 87
Su1053 - Bar704, a Potent and Selective Fxr Agonist Protects Against Intestinal Fibrosis 86
Investigation around the Oxadiazole Core in the Discovery of a New Chemotype of Potent and Selective FXR Antagonists 84
VARIABILITY IN INDUSTRIAL PRODUCTION AFFECTS PROBIOTICS ACTIVITY: IDENTIFICATION OF BATCHES OF PROBIOTIC VSL#3 THAT INCREASES INTESTINAL PERMEABILITY AND WORSENS COLITIS IN RODENTS 79
Tu1738 - The Aryl Hydrocarbon Receptor Mediates Anti-Inflammatory Activities of Natural and Synthetic Pelargonidines in Mouse Models of Colitis 78
Endocrine activities and adipogenic effects of bisphenol AF and its main metabolite 77
Introduction of Nonacidic Side Chains on 6-Ethylcholane Scaffolds in the Identification of Potent Bile Acid Receptor Agonists with Improved Pharmacokinetic Properties 77
Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets Formation 75
GPBAR1 (TGR5) LIGATION PROTECTS AGAINST COLITIS DEVELOPMENT BY REGULATING LEUKOCYTE TRAFFINKING AND PROMOTING A IL-10 DEPENDENT SHIFT IN THE M1/M2 PHENOTYPE 74
Targeting Bile Acid Receptors: Discovery of a Potent and Selective Farnesoid X Receptor Agonist as a New Lead in the Pharmacological Approach to Liver Diseases 73
Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis 70
GPBAR1 (TGR5) AGONISM REVERSES ENDOTHELIAL DYSFUNCTION AND LIVER INJURY IN A DIETETIC MODEL OF STEATOHEPATITIS 66
Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain 66
Tu1748 - Probiotics Beyond Taxonomy: Evidence that Anti-inflammatory Properties of Live Biotherapeutic Products Require Phenotypic Characterization 65
Organoids as ex vivo culture system to investigate infection-host interaction in gastric pre-carcinogenesis 57
Hyodeoxycholic acid derivatives as liver X receptor α and G-protein-coupled bile acid receptor agonists 47
Totale 4.851
Categoria #
all - tutte 23.638
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.638


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022436 0 92 2 14 11 4 20 113 9 43 57 71
2022/2023862 62 174 8 69 86 83 0 46 286 2 34 12
2023/2024291 18 31 8 6 5 3 79 18 3 14 66 40
2024/2025808 10 63 43 36 74 68 57 60 148 43 142 64
2025/20261.802 88 121 84 238 296 176 320 99 163 153 46 18
2026/202790 41 49 0 0 0 0 0 0 0 0 0 0
Totale 4.851